GVAG
NVAX icon

Great Valley Advisor Group’s Novavax NVAX Stock Holding History

Great Valley Advisor Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,624
Closed -$417K – 707
2022
Q1 		$417K Buy
5,624
+2,094
+59% +$187K 0.02% 420
2021
Q4 		$509K Buy
3,530
+1,348
+62% +$232K 0.03% 381
2021
Q3 		$453K Buy
2,182
+214
+11% +$47.2K 0.03% 381
2021
Q2 		$416K Buy
1,968
+103
+6% +$18.9K 0.03% 390
2021
Q1 		$338K Sell
1,865
-1,755
-48% -$350K 0.03% 381
2020
Q4 		$404K Sell
3,620
-23
-0.6% -$2.44K 0.04% 316
2020
Q3 		$394K Buy
+3,643
New +$444K 0.05% 290

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Great Valley Advisor Group's NVAX Position: Q2 2022 in Review

Great Valley Advisor Group sold out of Novavax (NVAX) in Q2 2022, closing a stake of 5,624 shares — an estimated $417K sold.

Great Valley Advisor Group first reported a position in NVAX in Q3 2020 and held it in 7 quarters. The position peaked at $509K in Q4 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Great Valley Advisor Group reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Great Valley Advisor Group sold 5,624 Novavax shares in Q2 2022, an estimated $417K.
  • Great Valley Advisor Group first reported a position in Novavax in Q3 2020 and held it in 7 quarters.
  • Great Valley Advisor Group's Novavax position peaked at $509K in Q4 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Great Valley Advisor Group's 13F filing for Q2 2022, filed 19 Jul 2022.